AIM ImmunoTech (AIM) Assets (2010 - 2026)
AIM ImmunoTech (AIM) reported Assets of $12.73 million for Q2 2026, up 208.3% from $4.13 million a year earlier and up 48.3% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, AIM ImmunoTech posted Assets of $5.78 million, down 32.8% from FY2024.
- Assets has declined for five consecutive years, with a five-year compound annual growth rate of -38.3% (FY2020 to FY2025).
- By year, Assets came in at $8.61 million in FY2024 (-55.6%), $19.38 million in FY2023 (-52.1%), $40.49 million in FY2022 (-29.8%) and $57.7 million in FY2021 (-10.7%).
- The Q2 2026 figure ranks as the highest quarterly Assets since Q3 2024.
- Year over year, Assets gained in two of the last eight quarters, with an average decline of 11.1%.
- The high point for year-over-year Assets in five years was Q2 2026 (growth of 208.3%); the low point was Q2 2025 (a decline of 73.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.59 million (Q1 2026), $5.78 million (Q4 2025) and $5.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 12.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.73 Mn |
| Mar 31, 2026 | 8.59 Mn |
| Dec 31, 2025 | 5.78 Mn |
| Sep 30, 2025 | 5.49 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 6.25 Mn |
| Dec 31, 2024 | 8.61 Mn |
| Sep 30, 2024 | 13.59 Mn |
| Jun 30, 2024 | 15.72 Mn |
| Mar 31, 2024 | 16.19 Mn |
| Dec 31, 2023 | 19.38 Mn |
| Sep 30, 2023 | 27.86 Mn |
| Jun 30, 2023 | 33.62 Mn |
| Mar 31, 2023 | 37.46 Mn |
| Dec 31, 2022 | 40.49 Mn |
| Sep 30, 2022 | 46.29 Mn |
| Jun 30, 2022 | 50.88 Mn |
| Mar 31, 2022 | 54.16 Mn |
| Dec 31, 2021 | 57.70 Mn |
| Sep 30, 2021 | 63.08 Mn |
API Access
AIM ImmunoTech Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();